Hims & Hers Health Inc. Stock News

Hims & Hers Health (HIMS -7.67%) stock is on a downward trend on both macro trends and news about GLP-1s. But this is still a growth stock investors should watch, which Travis Hoium explains in this video.

Hims & Hers Health Inc (NYSE:HIMS) stock is sitting out the broad market rally today, last seen down 8.4% to trade at $26.15.

Telehealth — a new frontier in healthcare that seeks to apply the creature comforts of the digital age to medical services is a field that carries much promise. However, most telehealth stocks haven't exactly been performing well as of late.

SAN FRANCISCO--(BUSINESS WIRE)--For most Americans, weight is more than just a number. It shapes our health, our mood, our confidence, our spending, and the decisions we make in our day to day lives. In fact, 75% of us think about our weight every single day, and 14% say it's constantly on our minds. At Hims & Hers (NYSE: HIMS), we know that health is personal, which is why we focus on making h...

Hims & Hers Health, Inc. has shown significant improvement in key unit economics, positioning it among top-tier SaaS companies in terms of scalability and growth potential. The company reported stellar Q3 FY2024 results with a 77% YoY revenue increase, driven by strong subscriber growth and high retention rates in personal health services. Despite regulatory risks and competition, HIMS' advance...

Every earnings season has its share of winners and losers, as well as top and bottom-line surprises and disappointments. This recent earnings season is no different.

Hims & Hers Health stock is substantially undervalued despite a massive YTD rally, presenting a strong buy opportunity due to a myriad of catalysts. The company demonstrates exponential revenue growth, improving operating margins, and successful customer acquisition cost reduction, driven by personalized solutions and innovative product formats. HIMS is financially strong with minimal debt and ...

Twenty-six new analysts joined Seeking Alpha in November, sharing diverse investment ideas highlighting their unique backgrounds and expertise. Top picks include U.S. Bancorp Preferred Series A, Hershey, and PepsiCo, emphasizing undervalued opportunities, dividend stability, and strategic growth potential. Analysts also spotlighted strong sell recommendations like BlackRock Science and Technolo...